Cardlytics Deferred Long Term Liab from 2010 to 2025
| CDLX Stock | USD 3.06 0.10 3.16% |
Deferred Long Term Liabilities | First Reported 2015-12-31 | Previous Quarter 139 K | Current Value 198 K | Quarterly Volatility 4.7 M |
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 35.6 M, as well as many indicators such as Price To Sales Ratio of 0.93, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
Cardlytics | Deferred Long Term Liab |
Latest Cardlytics' Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Cardlytics over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Cardlytics' Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Cardlytics Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 4,627,031 | |
| Geometric Mean | 1,799,795 | |
| Coefficient Of Variation | 116.01 | |
| Mean Deviation | 4,014,235 | |
| Median | 3,118,000 | |
| Standard Deviation | 5,368,028 | |
| Sample Variance | 28.8T | |
| Range | 17M | |
| R-Value | (0.21) | |
| Mean Square Error | 29.5T | |
| R-Squared | 0.04 | |
| Significance | 0.44 | |
| Slope | (236,696) | |
| Total Sum of Squares | 432.2T |
Cardlytics Deferred Long Term Liab History
About Cardlytics Financial Statements
Cardlytics investors use historical fundamental indicators, such as Cardlytics' Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 178.2 K | 169.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.